Evaluation of the Motus Gl CleanUp System During Screening Colonoscopy

NCT ID: NCT02161549

Last Updated: 2017-09-20

Study Results

Results available

Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.

View full results

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

71 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-07-31

Study Completion Date

2013-10-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Motus Gl is developing a single-use device that attaches to a standard colonoscope, thereby integrating colon cleansing, screening and treatment into one procedure.

The device creates turbulence within the colon using water jets. The colon's fecal fluids are evacuated by the system.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

63 eligible subjects who are allocated for a diagnostic screening colonoscopy were enrolled in the study. The assignment of the level of the bowel preparation agent was according to the physician decision. Following preparation, enrolled subjects were intubated and cleansed using a standard colonoscope with the Motus GI CleanUp device attached to it. At the end of the procedure, subjects were followed through discharge and at 48 hours post procedure for occurrence of adverse events.

40 subjects were enrolled under protocol Rev 1.0 used Motus GI CleanUp System Rev 1.0 31 subjects were enrolled under protocol Rev 2 used Motus GI CleanUp System Rev 1.5, due to improvement made to the study device including the following:

1. One head that irrigates and evacuates instead of two heads
2. Elimination of the grinding mechanism and the motor to reduce the pipes' diameters while keeping the same flow rate.
3. System adjustment to the above changes including updated software version.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

CRC

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Colonoscopy with MotusGi CleanUp System Rev 1.0

subjects indicated for colonoscopy procedure with CleanUp System Rev 1.0 , enrolled under protocol Rev 1.0

Motus Gl CleanUp System

Intervention Type DEVICE

Colonoscopy with MotusGi CleanUp System Rev 1.5

subjects indicated for colonoscopy procedure with CleanUp System Rev 1.5 , enrolled under protocol Rev 2.0

Motus Gl CleanUp System

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Motus Gl CleanUp System

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subjects in the age range of 50-69 years
* Subjects who are considered for routine screening colonoscopy
* Subjects with BMI within the range of 18.5-30
* Subject is willing to sign informed consent form

Exclusion Criteria

* History of G diseases or history of Colorectal cancer (personal or family)
* Previous major abdominal surgeries
* Medical status ASA grater or equal to 3
* Acute Gl symptoms, such as bleeding, unexplained weight loss, inflammatory bowel disease (lBD).
* Patients taking anticoagulants (e.g., Coumadin, Heparin, Clopidrogrel)
* Life-threatening condition
* Subjects who are unable or unwilling to cooperate with study procedures
* Severe Diverticula
Minimum Eligible Age

50 Years

Maximum Eligible Age

69 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Motus GI Medical Technologies Ltd

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Clinica San Rafael

Cadiz, , Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CP-MCU-SP-1211

Identifier Type: -

Identifier Source: org_study_id